Replies to post #242105 on Biotech Values

[usma67korea]

w/ TGTX failure, what competitor co's may benefit from this? IF any?

Earlier I saw Japanese co. failed in oral Covid pill which then saw ENTA and PRDS benefit from one less competitor pursuing same indication.

Any TGTX competitors in this or just a TGTX ?